1,957 reports of this reaction
12.5% of all CRISABOROLE reports
#1 most reported adverse reaction
DRUG INEFFECTIVE is the #1 most commonly reported adverse reaction for CRISABOROLE, manufactured by Pfizer Laboratories Div Pfizer Inc. There are 1,957 FDA adverse event reports linking CRISABOROLE to DRUG INEFFECTIVE. This represents approximately 12.5% of all 15,699 adverse event reports for this drug.
Patients taking CRISABOROLE who experience drug ineffective should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG INEFFECTIVE is a frequently reported adverse event for CRISABOROLE, accounting for a significant proportion of all reports.
In addition to drug ineffective, the following adverse reactions have been reported for CRISABOROLE:
The following drugs have also been linked to drug ineffective in FDA adverse event reports:
DRUG INEFFECTIVE has been reported as an adverse event in 1,957 FDA reports for CRISABOROLE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG INEFFECTIVE accounts for approximately 12.5% of all adverse event reports for CRISABOROLE, making it one of the most commonly reported side effect.
If you experience drug ineffective while taking CRISABOROLE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.